|
Targacept to begin phase 2 trials for its anti-inflammatory drug compound
Winston-Salem Journal … said that the studies involve its drug compound TC-6987 for disorders related to inflammation – in this instance asthma and Type 2 diabetes. … Targacept starts new trial for diabetes drug TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News